MTOR and myocardial ischemia: This increase in SGLT1 expression can be linked to the increased phosphorylation of secondary messengers such as ERK 1/2 and the mammalian target of rapamycin (mTOR), involved in the signaling pathways of cardiac ischemia/hypertrophy.